Cooper Companies (NASDAQ:COO) Announces Earnings Results

Cooper Companies (NASDAQ:COO) issued its quarterly earnings results on Thursday. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11, FiscalAI reports. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies updated its FY 2026 guidance to 4.580-4.660 EPS.

Cooper Companies Stock Up 2.8%

Shares of COO stock traded up $1.68 on Thursday, reaching $62.02. 3,915,194 shares of the company were exchanged, compared to its average volume of 2,227,562. The company has a market cap of $12.10 billion, a price-to-earnings ratio of 30.70, a PEG ratio of 1.53 and a beta of 0.87. The company has a 50-day moving average of $65.34 and a 200-day moving average of $74.64. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. Cooper Companies has a one year low of $58.89 and a one year high of $89.83.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Axxcess Wealth Management LLC raised its holdings in shares of Cooper Companies by 37.1% in the 4th quarter. Axxcess Wealth Management LLC now owns 9,980 shares of the medical device company’s stock worth $818,000 after acquiring an additional 2,698 shares during the last quarter. Corient Private Wealth LLC raised its holdings in shares of Cooper Companies by 17.0% in the 4th quarter. Corient Private Wealth LLC now owns 25,699 shares of the medical device company’s stock worth $2,106,000 after acquiring an additional 3,738 shares during the last quarter. Alberta Investment Management Corp acquired a new stake in shares of Cooper Companies in the 4th quarter worth about $1,582,000. Mercer Global Advisors Inc. ADV raised its holdings in shares of Cooper Companies by 94.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,893 shares of the medical device company’s stock worth $1,466,000 after acquiring an additional 8,707 shares during the last quarter. Finally, Vident Advisory LLC raised its holdings in shares of Cooper Companies by 476.6% in the 4th quarter. Vident Advisory LLC now owns 52,152 shares of the medical device company’s stock worth $4,274,000 after acquiring an additional 43,108 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on COO. Citigroup reaffirmed a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday, May 27th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday. Needham & Company LLC increased their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Finally, Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $87.00.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Quarterly EPS came in at $1.21, above the $1.10 consensus, showing better-than-expected profitability. View Press Release
• Positive Sentiment: Revenue reached $1.08 billion, topping the $1.05 billion estimate and signaling solid demand across the business. View Press Release
• Neutral Sentiment: Management raised FY 2026 EPS guidance to 4.58-4.66, which is slightly below the Street’s 4.62 estimate at the midpoint, suggesting the outlook is good but not a big upside surprise. View Press Release
• Neutral Sentiment: The company also kept revenue guidance roughly in line with expectations, limiting the chance of a major re-rating from guidance alone. View Press Release

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.